Posts Tagged: access to medicines


Unitaid’s Contradictory Approach to IP Rights Risks Progress

Founded in 2006 by the governments of France, the United Kingdom and several others, and financed by a combination of a tax on airline tickets and government grants, …
By Philip Stevens
2 months ago 1

Winning the Drug Development Debate

We create two new companies around academic inventions every day of the year. The critical role such companies play in drug development is clear. The successful integration …
By Joseph Allen
3 years ago 0

The UN has Better Things to do Than Destroy Innovation

The UN Panel unfortunately squandered its 9-month gestation period. It stuffed into one repository every long-discarded remnant of anti-patent and pro-price-control schemes buried in IP’s historic …
By Chris Gallagher
3 years ago 2

Are Patents the Reason Poor Countries Lack Healthcare?

A consistent charge against the patent system is that it denies the poor access to critical medicines. This belief led the UN Secretary General to launch his …
By Joseph Allen
3 years ago 3

The superbugs are here, but where are we?

Superbugs have powerful friends in high places. SCOTUS’s patent eligibility criteria emanating from Mayo/Alice’s mysterious “laws of nature” and credible reports of unremitting turndowns …
By Chris Gallagher
4 years ago 6

UN Access to Medicines Panel Undermines Bayh-Dole 

We cannot know what biological killer will next emerge, when it will be born and where globalization’s winds will take it. But we do know that …
By Chris Gallagher
4 years ago 1

UN Access to Medicine Recommendations Will Increase Human Suffering

The pending report of the UN Secretary General's High Level Panel on Access to Medicines not only attacks the patent system as predicted, but proposes giving the …
By Joseph Allen
4 years ago 7

The UN’s Misguided Focus on Patents as the Cause of Drug Shortages

Improving access to needed medicines for those suffering the ravages of disease in developing countries is a serious issue. There are many factors contributing to the problem …
By Joseph Allen
4 years ago 15

UN Panel on Access to Medicines Should Ensure Innovation by Preserving Market Incentives

The dilemma for developing countries is primarily a function of two things: lack of access to existing medicines and absence of innovation on the treatments and cures …